I
Inflammasome Therapeutics
Profile managed by Bizz Id
Estados Unidos
11-50 employees
2019
Description
Biotechnology company founded in 2019 in Newton, Massachusetts, developing therapies for inflammatory degenerative diseases including Alzheimer's, multiple sclerosis, AMD and type 2 diabetes. Its compound K8 (Kamuvudine) acts as a dual inflammasome inhibitor.